Cargando…

Correction: AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma

Detalles Bibliográficos
Autores principales:	Gu, Chunyan, Wang, Yajun, Zhang, Lulin, Qiao, Li, Sun, Shanliang, Shao, Miaomiao, Tang, Xiaozhu, Ding, Pinggang, Tang, Chao, Cao, Yuhao, Zhou, Yanyan, Guo, Mengjie, Wei, Rongfang, Li, Nianguang, Xiao, Yibei, Duan, Jinao, Yang, Ye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114437/ https://www.ncbi.nlm.nih.gov/pubmed/37072818 http://dx.doi.org/10.1186/s13046-023-02672-7

Ejemplares similares

AHSA1 is a promising therapeutic target for cellular proliferation and proteasome inhibitor resistance in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2022)

Targeting RFWD2 as an Effective Strategy to Inhibit Cellular Proliferation and Overcome Drug Resistance to Proteasome Inhibitor in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2021)

BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability
por: Tang, Xiaozhu, et al.
Publicado: (2021)

Elevated SFXN2 limits mitochondrial autophagy and increases iron-mediated energy production to promote multiple myeloma cell proliferation
por: Chen, Ying, et al.
Publicado: (2022)

A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing
por: Tang, Xiaozhu, et al.
Publicado: (2022)

CHEK1 and circCHEK1_246aa evoke chromosomal instability and induce bone lesion formation in multiple myeloma
por: Gu, Chunyan, et al.
Publicado: (2021)

CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2022)

Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma
por: Guo, Mengjie, et al.
Publicado: (2019)

Correction for: CD229 interacts with RASAL3 to activate RAS/ERK pathway in multiple myeloma proliferation
por: Lin, Zigen, et al.
Publicado: (2023)

Carfilzomib: A Promising Proteasome Inhibitor for the Treatment of Relapsed and Refractory Multiple Myeloma
por: Jayaweera, Shansa Pranami E., et al.
Publicado: (2021)

Steroid 5α-Reductase Type I Induces Cell Viability and Migration via Nuclear Factor-κB/Vascular Endothelial Growth Factor Signaling Pathway in Colorectal Cancer
por: Wei, Rongfang, et al.
Publicado: (2020)

In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma
por: Zhou, Hui, et al.
Publicado: (2020)

NAT10 promotes cell proliferation by acetylating CEP170 mRNA to enhance translation efficiency in multiple myeloma
por: Wei, Rongfang, et al.
Publicado: (2022)

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
por: Gu, Yanyan, et al.
Publicado: (2020)

DAZAP1 facilitates the alternative splicing of KITLG to promote multiple myeloma cell proliferation via ERK signaling pathway
por: Zhou, Yanyan, et al.
Publicado: (2022)

Skin infections in male pupils of primary schools in Al Ahsa
por: Amri, Montassar, et al.
Publicado: (2013)

Mental Stigma Among Al-Ahsa Population in Saudi Arabia
por: Alamer, Mohammed, et al.
Publicado: (2021)

Proteasome Inhibitors for the Treatment of Multiple Myeloma
por: Ito, Shigeki
Publicado: (2020)

Quantitative Phosphoproteomics of Proteasome Inhibition in Multiple Myeloma Cells
por: Ge, Feng, et al.
Publicado: (2010)

Review on circular RNAs and new insights into their roles in cancer
por: Tang, Xiaozhu, et al.
Publicado: (2021)

Investigation on papillomavirus infection in dromedary camels in Al-Ahsa, Saudi Arabia
por: Khalafalla, Abdelmalik Ibrahim, et al.
Publicado: (2017)

Patient Satisfaction With Primary Healthcare Services in Al-Ahsa, Saudi Arabia
por: Albahrani, Suha, et al.
Publicado: (2022)

Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate
por: Brünnert, Daniela, et al.
Publicado: (2023)

Recent progress on the total synthesis of acetogenins from Annonaceae
por: Li, Nianguang, et al.
Publicado: (2008)

New proteasome inhibitors in the treatment of multiple myeloma
por: Hungria, Vania Tietsche de Moraes, et al.
Publicado: (2019)

Paradoxical resistance of multiple myeloma to proteasome inhibitors by decreased levels of 19S proteasomal subunits
por: Acosta-Alvear, Diego, et al.
Publicado: (2015)

Phenology and production of Hassaoui grapevines as affected by climate anomalies in Al Ahsa region
por: Alturki, Saleh M.
Publicado: (2022)

Risk Assessment of Varicose Veins Among Teachers in Al-Ahsa, Saudi Arabia
por: Busbaih, Zaki, et al.
Publicado: (2022)

Characterizing physical and hydraulic properties of soils in Al-Ahsa, Kingdom of Saudi Arabia
por: Al-Saeedi, Abdullah H.
Publicado: (2022)

Diabetic Neuropathy: Prevalence and Impact on Quality of Life in Al-Ahsa, Saudi Arabia
por: Alhajji, Arwa M, et al.
Publicado: (2022)

Correction: Patient Satisfaction With Primary Healthcare Services in Al-Ahsa, Saudi Arabia
por: Albahrani, Suha, et al.
Publicado: (2023)

Proteasome inhibition and its therapeutic potential in multiple myeloma
por: Chari, Ajai, et al.
Publicado: (2010)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
por: Merin, Noah M., et al.
Publicado: (2014)

Ixazomib: An Oral Proteasome Inhibitor for the Treatment of Multiple Myeloma
por: Ramirez, Krista G.
Publicado: (2017)

Proteasome inhibition: the dawn of novel therapies in multiple myeloma
por: Engelhardt, Monika, et al.
Publicado: (2022)

AHSA1 Promotes Proliferation and EMT by Regulating ERK/CALD1 Axis in Hepatocellular Carcinoma
por: Zhang, Jiakang, et al.
Publicado: (2022)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

Public attitude and justification to purchase antibiotics in the Eastern region Al Ahsa of Saudi Arabia
por: Emeka, Promise M., et al.
Publicado: (2014)

Patients’ Awareness of Their Rights and Responsibilities: A Cross-Sectional Study From Al-Ahsa
por: Aljeezan, Meataz K, et al.
Publicado: (2022)

Patient’s Perspective on Factors Affecting Health-Seeking Behavior in Al-Ahsa, Saudi Arabia
por: Almaqhawi, Abdullah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iflslijs8p217n40pg7tp99d9p